GFM
GF Fund Management Portfolio holdings
AUM
$4.97B
This Quarter Return
+21.29%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$4.97B
AUM Growth
+$710M
(+17%)
Cap. Flow
+$57.6M
Cap. Flow
% of AUM
1.16%
Top 10 Holdings %
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41
Top Buys
| 1 |
British American Tobacco
BTI
|
$31.2M |
| 2 |
SAP
SAP
|
$28.7M |
| 3 |
Robinhood
HOOD
|
$28.4M |
| 4 |
UnitedHealth
UNH
|
$25.3M |
| 5 |
Celestica
CLS
|
$20.1M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$36.5M |
| 2 |
TSMC
TSM
|
$32.1M |
| 3 |
Meta Platforms (Facebook)
META
|
$28.1M |
| 4 |
KE Holdings
BEKE
|
$20.4M |
| 5 |
Trip.com Group
TCOM
|
$16.6M |
Sector Composition
| 1 | Technology | 46.23% |
| 2 | Consumer Discretionary | 14.24% |
| 3 | Communication Services | 13.85% |
| 4 | Consumer Staples | 7.1% |
| 5 | Healthcare | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
STAG Industrial
STAG
$6.9B
| $119K | ﹤0.01% |
3,290
-161
| -5% | -$5.84K |
|
352
Alkermes
ALKS
$4.94B
| $119K | ﹤0.01% |
4,143
| – | – |
|
353
Green Plains
GPRE
$698M
| $114K | ﹤0.01% |
18,830
-841
| -4% | -$5.07K |
|
354
First Industrial Realty Trust
FR
$6.92B
| $112K | ﹤0.01% |
2,335
-172
| -7% | -$8.28K |
|
355
Vaalco Energy
EGY
$399M
| $110K | ﹤0.01% |
30,607
-440
| -1% | -$1.59K |
|
356
Essential Properties Realty Trust
EPRT
$6.1B
| $110K | ﹤0.01% |
3,457
+136
| +4% | +$4.34K |
|
357
ADMA Biologics
ADMA
$4.03B
| $110K | ﹤0.01% |
6,053
| – | – |
|
358
Vornado Realty Trust
VNO
$7.93B
| $110K | ﹤0.01% |
2,878
-191
| -6% | -$7.3K |
|
359
GE Vernova
GEV
$158B
| $110K | ﹤0.01% |
207
-1,561
| -88% | -$826K |
|
360
Clean Energy Fuels
CLNE
$546M
| $106K | ﹤0.01% |
54,463
-992
| -2% | -$1.93K |
|
361
Vaxcyte
PCVX
$4.29B
| $104K | ﹤0.01% |
3,192
| – | – |
|
362
American Healthcare REIT
AHR
$7.2B
| $103K | ﹤0.01% |
2,799
-100
| -3% | -$3.67K |
|
363
Terreno Realty
TRNO
$6.1B
| $102K | ﹤0.01% |
1,817
-72
| -4% | -$4.04K |
|
364
CareTrust REIT
CTRE
$7.56B
| $101K | ﹤0.01% |
3,310
-238
| -7% | -$7.28K |
|
365
Krystal Biotech
KRYS
$4.35B
| $101K | ﹤0.01% |
736
| – | – |
|
366
Cytokinetics
CYTK
$6.34B
| $99.8K | ﹤0.01% |
3,021
| – | – |
|
367
Rhythm Pharmaceuticals
RYTM
$6.78B
| $99.4K | ﹤0.01% |
1,573
| – | – |
|
368
Ryman Hospitality Properties
RHP
$6.35B
| $99.2K | ﹤0.01% |
1,005
-73
| -7% | -$7.2K |
|
369
PTC Therapeutics
PTCT
$4.55B
| $96.4K | ﹤0.01% |
1,974
| – | – |
|
370
Akero Therapeutics
AKRO
$3.58B
| $95.4K | ﹤0.01% |
1,787
| – | – |
|
371
Healthcare Realty
HR
$6.35B
| $93.3K | ﹤0.01% |
5,882
-495
| -8% | -$7.85K |
|
372
Merus
MRUS
$5.1B
| $92.2K | ﹤0.01% |
1,753
| – | – |
|
373
Acadia Pharmaceuticals
ACAD
$4.26B
| $91.9K | ﹤0.01% |
4,260
| – | – |
|
374
Arcellx
ACLX
$4.03B
| $91.1K | ﹤0.01% |
1,384
| – | – |
|
|
SWTX
375
DELISTED
SpringWorks Therapeutics
SWTX
| $89.5K | ﹤0.01% |
1,905
| – | – |
|